Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.37 USD | +5.46% | -3.67% | +322.83% |
08/05 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
08/05 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+322.83% | 235.22Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+45.66% | 4.07TCr | |
-10.72% | 2.71TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- Janux Therapeutics : Evercore ISI Starts Janux Therapeutics at Outperform With $35 Price Target